- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Lupin Limited — Updates, 04-02-2026: Press Release
04-02-2026 | 08:46 pm
04-02-2026 | 08:46 pm
Lupin launched Topiramate Extended-Release Capsules in the US market, targeting seizures and migraine. This new product has an estimated annual sales potential of USD 164 million, boosting its US portfolio.
No comments yet. Be the first to comment!